homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

October 12, 2017

Impel NeuroPharma

Impel NeuroPharma, a Seattle biotech company, named Jon Congleton president and CEO. Impel develops intranasal drug treatments for central nervous system disorders. He was president and CEO of Nivalis Therapeutics. The firm's co-founder and interim CEO, John Hoekman, will remain as executive vice president and chief scientific officer.




Email or user name:
Password:
 
Forgot password? Click here.